Pharmacolog enters LOI with Knoware in Belgium
Pharmacolog i Uppsala AB (publ) has signed a Letter of Intent (LOI) regarding product integration with Knoware sa/nv which is the editor of ComeoCare™, the leading medication management system in Belgium. The idea is that the letter of intent should lead to a comprehensive solution that provides added value for hospital pharmacies.
Earlier this year, Pharmacolog announced a new strategic direction for commercial development. In addition to the introduction of a SaaS (Software as a Service) model for the analytical software, the network of distributors and partners will gradually be broadened to ensure high sales growth. One of the partners that Pharmacolog has identified as suitable for product integration is Knoware. Their product ComeoCare™, the leading medication management system in Belgium, offers a comprehensive solution for the prescription, preparation and administration of medication treatments for patients suffering from cancer. Oncologists, pharmacists, and nurses collaborate efficiently, increasing safety and freeing up more time to care for the patients. The integration of PrepLog™ for quality control of compounded pharmaceuticals with ComeoCare™ is subject to project feasibility outcome but the intention is that it will lead to a comprehensive solution that provides added value for hospital pharmacies.
Frederic Costenoble, Managing Partner of Knoware comments: "ComeoCare™ can run as a stand-alone web application, but its true strength comes alive when it is integrated with other solutions in the hospital. We look forward to integrating PrepLog™ with ComeoCare™, and thereby facilitating the quality control of potent pharmaceuticals at hospital pharmacies."
Lars Gusch, CEO of Pharmacolog comments: "We are very pleased to start a collaboration with Knoware since implementing quality control in hospital pharmacies requires a seamless integration in the overall workflow."
More information about ComeoCare™ can be found on www.comeocare.com.